Results for this period
Full year1 April 2025–31 March 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The increase in operating profit and profit for the year was mainly due to the reversal of impairment losses recorded in the previous consolidated fiscal year and other factors.
No applicable matters. The filing states, "There are no applicable matters."
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥53,449 million (YoY +0.6%) |
| Operating profit | ¥4,319 million (YoY +78.5%) |
| Ordinary income | ¥4,195 million (YoY +92.9%) |
| Profit attributable to owners of the parent | ¥2,958 million (YoY +96.9%) |
| Net income per share | ¥74.18 |
| Operating Margin | 8.1% |
| Equity ratio | End of the current fiscal period 39.2% / End of previous period 32.7% |
| Total assets | ¥37,686 million |
| Net assets | ¥14,770 million |
| Cash flows from operating activities | ¥4,534 million |
| Cash flows from investing activities | ¥-2,085 million |
| Cash flows from financing activities | ¥-2,406 million |
| Cash and cash equivalents at end of period | ¥3,968 million |
| Full-year earnings forecast | Net Sales ¥56,910 million (YoY +6.5%) / Operating profit ¥4,140 million (YoY -4.1%) / Ordinary income ¥3,950 million (YoY -5.8%) / Net income ¥2,540 million (YoY -14.0%) |
| Annual Dividend Forecast | ¥23 → ¥20（-13.0%） |
| Payout ratio | 31.4% |
| Segment revenue | Mushroom business ¥37,471 million (YoY +1.9%) / Other ¥373 million (YoY +15.9%) / Maitake mushrooms ¥20,264 million (YoY +1.0%) / King oyster mushrooms ¥3,973 million (YoY +3.9%) / Bunashimeji mushrooms ¥7,948 million (YoY +5.1%) / Other mushrooms ¥5,284 million (YoY -1.0%) |
| Segment profit | Mushroom business ¥4,384 million / Other ¥-98 million |
| Depreciation and amortization | ¥2,292 million |
| Impairment loss | ¥98 million |
| Disclosure regarding the going concern assumption | No applicable matters. The filing states, "There are no applicable matters." |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 39,910,700 Shares |
| Treasury Shares at Period-End | 27,878 Shares |
| Factors Behind Changes in Business Performance | The increase in operating profit and profit for the year was mainly due to the reversal of impairment losses recorded in the previous consolidated fiscal year and other factors. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase in operating profit and profit for the year for the fiscal year ended March 2026 was mainly due to the reversal of impairment losses recorded in the previous consolidated fiscal year and other factors. For the fiscal year ending March 2027, the company expects higher material costs, labor costs, sales promotion expenses and advertising expenses, among other factors.